Phase II trial shows retroperitoneal lymph node dissection provides viable management with low long-term morbidity in early metastatic seminoma, indicating an effective surgical alternative.
RPLND is a treatment option for testicular seminoma with clinically low-volume retroperitoneal lymphadenopathy and is associated with low long-term morbidity.
No takes yet. Share an insight, caveat, or question.
Daneshmand et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: